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Abstract 24 
Activation of TLRs by microbial molecules triggers intracellular signaling cascades and the expression of 25 
cytokines, as IL-10. Il10 expression is tightly controlled to ensure effective immune responses, whilst 26 
preventing pathology. Maximal TLR-induction of Il10 transcription in Mɸ requires signaling through the 27 
MAPKs ERK and p38. Signals via p38 downstream of TLR4 activation also regulate IL-10 at the post-28 
transcriptional level, but whether this mechanism operates downstream of other TLRs is not clear. We 29 
compared the regulation of IL-10 production in TLR2 and TLR4 stimulated BM-derived Mɸ (BMMɸ) 30 
and found different stability profiles for the Il10 mRNA. TLR2 signals promoted a rapid induction and 31 
degradation of Il10 mRNA, whereas TLR4 signals protected the Il10 mRNA from rapid degradation, due 32 
to the activation of Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) and enhanced 33 
p38 signaling. Consequently, TLR4 is a stronger inducer of IL-10 secretion than TLR2. Our study 34 
provides a molecular mechanism for the differential IL-10 production by TLR2- or TLR4-stimulated 35 
BMMɸ, showing that p38-induced stability is not common to all TLR signaling pathways. Furthermore, 36 
this mechanism is also observed upon bacterial activation of TLR2 or TLR4 in BMMɸ, thus contributing 37 
to IL-10 modulation in these cells in an infection setting.  38 
39 
3 
Introduction 40 
TLRs, a class of germ-line encoded receptors, play an important role in the recognition of 41 
microorganisms and initiation of innate immune responses [1]. Members of the TLR family recognize 42 
different molecular patterns in microbes, from peptidoglycan to polysaccharides, proteins and nucleic 43 
acids [1]. TLR triggering leads to a specific cellular transcriptional program with the expression of 44 
different immune mediators, such as cytokines [1]. The activation of intracellular signaling cascades upon 45 
TLR stimulation by PAMPs relies on the presence of the signaling adaptors MyD88 and/or Toll/IL-1 46 
receptor-domain-containing adaptor inducing interferon IFN-β (TRIF) [1]. MyD88 is a common signaling 47 
adaptor used by all TLRs with the exception of TLR3, which only activates the TRIF dependent pathway. 48 
Triggering of TLR4 by its ligand, LPS, is the only known example of recruitment of both MyD88 and 49 
TRIF [1]. In this case, whereas both MyD88 and TRIF contribute to full pro-inflammatory cytokine gene 50 
expression, only the TRIF pathway is involved in the induction of type I IFN downstream of TLR4 [2-5]. 51 
 In addition to pro-inflammatory cytokine secretion, TLR signaling also leads to the production of 52 
IL-10 by innate immune cells. IL-10 is a powerful anti-inflammatory cytokine produced by many cells of 53 
the immune system, including innate immune cells such as Mɸ [6]. Strict regulation of the balance 54 
between IL-10 production and the pro-inflammatory immune response during infection is essential to 55 
achieve clearance of the pathogen in the absence of immunopathology, while at the same time avoiding 56 
the establishment of chronic infection [7-9]. IL-10 production by TLR4-activated Mɸ or DCs requires 57 
both MyD88 and TRIF signals [10]. Moreover, not only the TNF receptor-associated factor (TRAF) 6 has 58 
been shown to be essential for the MyD88 pathway and involved in the signaling of TRIF [11], but also 59 
TRAF3 recruitment by either adaptor is fundamental for IL-10 production [3]. Overall, whereas the 60 
molecular pathways mediated by MyD88 and implicated in IL-10 regulation are well understood, less is 61 
known of the specific contribution of TRIF. 62 
Several molecular mechanisms for Il10 gene regulation have been described, including epigenetic control, 63 
the activation of specific intracellular signaling cascades, the action of certain transcription factors and 64 
4 
post-transcriptional control [6]. Although these broad mechanisms likely operate in all IL-10-producing 65 
cells, cell-specific factors have also been described [6]. For example, a specific NF-κB-binding enhancer 66 
sequence at the Il10 locus regulates Il10 transcription in Mɸ and DCs stimulated via TLRs, but not in IL-67 
10-producing T cells [12]. In addition to NF-κB, other signaling cascades have been implicated in the 68 
regulation of IL-10 induction by TLR-activated Mɸ and DCs, including the MAPKs ERK [3, 13-17] and. 69 
p38 [13, 14, 18-22]. Indeed, ERK activation is required for IL-10 expression in different cells, from Mɸ 70 
and DCs to Th cells [6]. ERK activation upregulates the transcription factor cFOS, which in turn 71 
enhances IL-10 transcription [15, 17]. Additionally, ERK activation has been shown to lead to the 72 
induction of IL-10 by increasing the IL10 locus accessibility to the binding of transcription factors [13]. 73 
Regulation of IL-10 transcription by p38 has also been described, and shown to involve the transcription 74 
factor Sp1 [18] and the activation of the downstream kinases MSK1 and MSK2 and CREB 75 
phosphorylation [23]. Activation of p38 has been further implicated in the post-transcriptional regulation 76 
of IL-10 by Mɸ in response to TLR4 ligation by helping to protect the Il10 mRNA from rapid 77 
degradation induced by the RNA binding protein tristetraprolin (TTP) [24]. Consistent with a role for 78 
TTP in inducing the rapid degradation of the Il10 mRNA, TTP deficient (-/-) Mɸ show elevated levels of 79 
Il10  mRNA upon TLR4 stimulation [25]. Other post-transcriptional mechanisms for Il10 gene regulation 80 
have been described, including the participation of certain microRNAs [26, 27]. Targeting mRNA 81 
stability is therefore an important mechanism for the regulation of IL-10 production, and indeed the 82 
production of other cytokines [28]. However, this mechanism has been mainly studied downstream of 83 
TLR4 and it is not clear how it operates downstream of other TLRs. 84 
 In this study, we compared the induction of IL-10 in Mɸ stimulated via the TLR2 and TLR4 85 
ligands, Pam3CSK4 and LPS, respectively, as well as whole bacteria which predominantly signal through 86 
either of these TLRs. We have found that independently of the stimuli, a peak of Il10 mRNA was 87 
observed as early as 1 h post-stimulation. However, whereas TLR2 signaling led to a rapid degradation of 88 
Il10 mRNA, TLR4 signals contributed to increased stability of Il10 mRNA. This increased Il10 mRNA 89 
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stability was dependent on TRIF-mediated activation of the MAPK p38 signaling pathway. We thus 90 
provide evidence that the TRIF pathway regulates IL-10 production at the post-transcriptional level, thus 91 
discriminating between TLR2 and TLR4 activation of Mɸ. Furthermore, we show that triggering of Mɸ 92 
by TLR2- or TLR4-activating bacteria impacts IL-10 secretion by these cells, suggesting a potential 93 
relevance of the described mechanism for modulating the course of the immune response during 94 
infection.95 
6 
RESULTS 96 
Distinct post-transcriptional regulation of IL-10 through TLR2 versus TLR4 signaling in 97 
macrophages 98 
To dissect the molecular mechanisms regulating the initial steps of Il10 gene expression in BMMɸ 99 
stimulated via TLR2 or TLR4, we compared the kinetics of mRNA expression in response to ligands 100 
Pam3CSK4 and LPS. The dose of TLR2 and TLR4 agonists used corresponded to maximum IL-10 101 
production by stimulated BMMɸ, as measured by immunoassay (Supplemental Fig. 1). Both stimuli 102 
induced a peak of Il10 mRNA at 1 h post-stimulation (Fig. 1A). Strikingly, the Il10  mRNA induced upon 103 
TLR2 activation of BMMɸ rapidly declined, with much lower levels detected at 3 h post-stimulation (Fig. 104 
1A). This was in contrast to TLR4 triggering of BMMɸ, where the amount of Il10 mRNA remained 105 
constant between 1 h and 3 h post-stimulation(Fig. 1A). The profile of Il10 mRNA observed upon TLR2 106 
stimulation (Fig. 1A) is compatible with a rapid degradation of Il10 mRNA. To test this hypothesis, we 107 
assessed the stability of the TLR2- or TLR4-induced Il10 mRNA, by adding ActD to the BMMɸ cultures 108 
at 1 h post-stimulation. As shown in Fig. 1B, while the Il10 mRNA induced by the TLR2 agonist was 109 
rapidly degraded upon the addition of ActD, Il10 mRNA induced by TLR4 showed a prolonged t1/2. In 110 
line with this, the IL-10 protein resulting of TLR2 versus TLR4 stimulation of BMMɸ was different, with 111 
higher quantities of IL-10 being secreted upon TLR4 activation (Fig. 1C). Of note, at 3 hours post-112 
stimulation with LPS the Il10 mRNA was unstable (Supplemental Fig. 2A), suggesting that post-113 
transcriptional mechanisms operate with either TLR, albeit with a different kinetics. We next investigated 114 
the Il10 post-transcriptional regulation using another MyD88-dependentTLR stimulus. The Il10 115 
transcription and mRNA stability profile induced in BMMɸ upon TLR9 triggering with CpG, which like 116 
TLR2 signals via MyD88 alone, was similar to that induced upon TLR2 activation (Fig. 1D, E and F). 117 
 118 
 119 
 120 
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TRIF signaling enhances the stability of Il10 mRNA via prolonged p38 activation 121 
Next we investigated the molecular mechanism underlying the enhanced Il10 mRNA stability upon TLR4 122 
signaling. Since a major difference between TLR2 (and TLR9) versus TLR4 signaling pathways is the 123 
recruitment of TRIF in the case of TLR4 but not TLR2 (or TLR9), and as TRIF-dependent signals have 124 
been implicated in IL-10 production by Mɸ [10], we hypothesized that TRIF may play a role in the 125 
observed differences. To test this, we generated BMMɸ from WT or TRIF-/- mice and stimulated the 126 
cultures with LPS for 1 h. At this time point, ActD was added and the amount of Il10 mRNA measured 127 
overtime by real-time PCR. We observed that the absence of TRIF significantly decreased the stability of 128 
Il10 mRNA upon TLR4 stimulation, leading to its degradation (Fig. 2A). The amount of IL-10 protein 129 
detected in TLR4-stimulated cultures of TRIF-/- BMMɸ was significantly lower than that observed for 130 
WT BMMɸ (Fig. 2B). In the absence of TRIF the Il10 transcription after TLR4 stimulation of BMMɸ 131 
was decreased (Supplemental Fig. 2B), suggesting that the TRIF pathway is also important to provide 132 
transcriptional enhancing signals. 133 
Both p38 and ERK have been extensively implicated in the regulation of Il10 expression [6] and a 134 
role for p38 in the post-transcriptional regulation of Il10 has also been described [24]. We therefore 135 
investigated whether the differential activation of these MAPKs was involved in the observed post-136 
transcriptional regulation of Il10 via TLR4/TRIF. We compared the levels of p38 and ERK 137 
phosphorylation upon TLR2 and TLR4 stimulation of WT BMMɸ. Although over the first 60 min post-138 
stimulation the activation of p38 was similar between TLR2 and TLR4, after that time point, a decrease in 139 
p38 activation was observed in Pam3CSK4-stimulated cells, which was less pronounced in the case of 140 
LPS-stimulated cells (Fig. 3A). TLR2 triggering led to a faster activation of ERK than TLR4 signaling, 141 
but the deactivation of this MAPK was similar to both signals (Fig. 3B). We next investigated in more 142 
detail the enhanced p38 activation and found that it was dependent on TRIF signals (Fig. 3C). ERK 143 
phosphorylation in the absence of TRIF was also decreased (Fig. 3D). We then tested the impact of 144 
inhibiting the activation of p38 or ERK signaling on the stability of Il10 mRNA, by stimulating WT 145 
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BMMɸ with LPS and, at 50 min post-stimulation, adding specific inhibitors for these MAPKs. We chose 146 
to add the chemical inhibitors at 50 min post-stimulation to minimize effects on the initial induction of 147 
Il10 transcription. As shown in Fig. 3E and F, inhibition of p38 led to the degradation of the Il10 mRNA, 148 
whereas inhibition of ERK did not. In line with this, inhibition of p38 activation had a stronger effect on 149 
IL-10 protein than ERK blockade (Fig. 3G and H). Of note, other p38 (BIRB) and ERK (PD184352 and 150 
U0126) inhibitors were used with similar results (data not shown). 151 
In summary, our data show that TRIF signals contribute to regulate IL-10 at the post-transcriptional level 152 
through a mechanism that involves enhanced p38 activation. 153 
 154 
TTP deficiency impacts Il10 mRNA stability early upon TLR2 stimulation of BMMɸ 155 
The RNA binding protein TTP has been described to target Il10 mRNA and induce its rapid degradation 156 
[24, 25]. p38 activation has been shown to inhibit TTP, thus promoting an increase of the t1/2 of Il10 157 
mRNA [24, 25, 29, 30]. Considering these reports and our findings showing that in TLR2-stimulated 158 
BMMɸ a rapid degradation of the Il10 mRNA occurs, in parallel with a reduced activation of p38, we 159 
next investigated the stability of TLR2-induced Il10 mRNA in the absence of TTP. WT or TTP-/- BMMɸ 160 
were stimulated for 1 h with LPS or Pam3CSK4 and at that time ActD was added to the cultures and Il10 161 
mRNA measured by real-time PCR. As shown in Fig. 4A, LPS stimulation in the absence of TTP did not 162 
result in increased Il10 mRNA stability at this time point. However, when the cells were stimulated with 163 
Pam3CSK4 a slight but significant increase in Il10 mRNA t1/2 was observed in the absence of TTP (Fig. 164 
4B). For both LPS and Pam3CSK4 stimuli, an increase in IL-10 protein secretion was observed in TTP 
-
/
-
 165 
cells at 6 h post-stimulation (Fig. 4C and D). This is in line with previous reports showing that at later 166 
time points post-stimulation with LPS, the absence of TTP increases the stability of the Il10 mRNA with 167 
consequent increase on IL-10 production [24, 25, 29, 30]. We herein show that in the case of TLR2 168 
activation, the absence of TTP influences the Il10 mRNA stability at an earlier time point than with 169 
TLR4. The transcriptional profile of TTP observed in macrophages upon TLR2 or TLR4 activation was 170 
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similar (Fig. 4E). We also addressed the contribution of TRIF signals for TTP expression and found that 171 
in macrophages stimulated with LPS the absence of TRIF decreased the expression of TTP (Fig. 4F). 172 
These data suggest that the differences observed for the stability of the Il10 mRNA do not reflect or 173 
correlate to specific changes in the expression of TTP. 174 
 175 
Differential post-transcriptional regulation of IL-10 by TLR2 versus TLR4 upon BMMɸ 176 
stimulation with bacteria 177 
Our findings unveil a novel link between TRIF and IL-10 post-transcriptional regulation, mediated by 178 
p38 and partly by TTP. However, these findings were obtained using TLR stimulation with chemically 179 
pure, single ligands. We sought to investigate if the described mechanism was also in place when BMMɸ 180 
were stimulated with bacteria. To test that, we stimulated WT BMMɸ with bacteria described in the 181 
literature to mainly require TLR2 ligation, such as M. tuberculosis strain H37Rv [31] and L. 182 
monocytogenes [32], or TLR4 ligation, such as E. coli and S. enteriditis [33], for maximal BMMɸ 183 
activation. In agreement with the data from the respective TLR ligands, M. tuberculosis stimulation of 184 
BMMɸ, which requires TLR2 to induce IL-10, led to a rapid degradation of Il10 mRNA, whereas Il10 185 
mRNA induced upon stimulation of these cells with E. coli, which predominantly induces IL-10 via 186 
TLR4, was stable over time (Fig. 5A). In further support of our data, L. monocytogenes, which signals 187 
mainly through TLR2 showed rapid degradation of induced Il10 mRNA, whereas S. enteriditis, which 188 
mainly signals through TLR4 resulted in the induction Il10 mRNA which was stable over time (Fig. 5B). 189 
To investigate whether TRIF and p38 activation also accounted for the increased stability of the 190 
Il10 mRNA observed in response to bacteria signaling through TLR4, we further dissected the 191 
stimulation of BMMɸ with E. coli. Again Il10 mRNA induced by E. coli stimulation of BMMɸ lost its 192 
stability in the absence of TRIF or p38 activation (Fig. 5C and D). In addition, the amount of IL-10 193 
protein secreted in the absence of TRIF or in the presence of the p38 inhibitor was lower than that 194 
obtained for WT cells in response to E. coli (Fig. 5E and F). Additionally, the comparison of BMMɸ 195 
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activation by M. tuberculosis H37Rv or E. coli showed that the relative amounts of Il10 and TTP mRNA 196 
and of p38 activation followed the pattern described for TLR2 versus TLR4 activation with chemical 197 
agonists (Supplemental Fig. 3A-C). Also, in the absence of TRIF, the Il10 and TTP mRNA and p38 198 
activation were decreased in BMMɸ stimulated with E. coli, recapitulating the findings with LPS 199 
stimulation of these cells (Supplemental Fig. 3D-F). 200 
Taken together, our study suggests that recognition of pathogens by distinct TLRs has an impact 201 
on the amount of IL-10 produced by BMMɸ. Our data demonstrate that this results from post-202 
transcriptional mechanisms of Il10 mRNA stabilization involving TLR4/TRIF/p38 signaling when 203 
BMMɸ are stimulated with TLR4-activating microbes. This reveals an important mechanism in 204 
modulating the course of the immune response. 205 
206 
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DISCUSSION 207 
IL-10 plays a fundamental role in regulating inflammation and the level of activation of adaptive immune 208 
responses [34]. Several immune cells produce IL-10 in response to various stimuli, for example ligands 209 
for PRRs in Mɸ [6]. Among the extensive family of PRRs, TLRs are amongst the best characterized 210 
members, with many studies contributing to the understanding of the intracellular signaling cascades, as 211 
well as of the changes in the cell transcriptome, triggered by individual TLRs [1]. The regulation of Il10 212 
gene transcription induced by TLR activation has also been an active area of research owing to the 213 
important immuno-regulatory roles of this cytokine [6]. Several studies demonstrate the existence of 214 
various layers for modulating IL-10 production, from epigenetic control, to transcriptional and post-215 
transcriptional regulation [6].  216 
By comparing TLR2- versus TLR4-stimulated BMMɸ, we studied the molecular mechanisms 217 
leading to the post-transcriptional regulation of Il10 mRNA induced by these stimuli. Our findings show 218 
that TLR4 signals increase the t1/2 of the Il10 mRNA, via enhanced p38 activation which was dependent 219 
on TRIF. Despite initial transcriptional induction of the Il10 gene at 1 hr post stimulation, both TLR2 and 220 
TLR9 that lack the activation of the TRIF signaling cascade, failed to sustain the t1/2 of Il10 mRNA 221 
subsequent to this. Our study confirms the role of TRIF for maximal IL-10 production by TLR4-222 
stimulated BMMɸ [10]. TRIF signals promote both a stronger transcription of the Il10 gene and an 223 
increased stability of the Il10 mRNA, thus resulting in more IL-10 protein produced by TLR4- than 224 
TLR2-activated Mɸ.  Therefore, our study suggests that different TLRs regulate IL-10 expression in 225 
different ways, perhaps allowing the fine-tuning of IL-10 production to suit infections with different 226 
pathogens and/or commensals. Further studies are required to address whether the role of TRIF in 227 
enhancing p38 activity and Il10 mRNA stability is direct or indirect. A possible candidate for an indirect 228 
role of TRIF in this process is type I IFN. On one hand, TLR2 agonists are poor inducers of IFN-β, as 229 
opposed to TLR4 ligands that induce IFN-β mRNA independently of MyD88 signaling [35]. On the other 230 
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hand, IFN-β has been implicated in the induction and sustained expression of IL-10 by LPS-stimulated 231 
BMMɸ [35-38]. 232 
The mechanism proposed in our study was recapitulated upon stimulation of BMMɸ with 233 
microbes, such as M. tuberculosis, L. monocytogenes, E. coli and S. enteriditis. Therefore, it is possible 234 
that the manipulation of specific TLR activation by bacteria will have implications on the amounts of IL-235 
10 secreted by Mɸ. In this sense, bacteria that preferentially trigger TLR4 may be manipulating the 236 
immune system to increase the amounts of IL-10, thus compromising the full efficacy of the immune 237 
response. It will be interesting to investigate if these differential pathways regulating IL-10 at the post-238 
transcriptional level also occur in cells other than Mɸ, or in Mɸ located at different anatomical sites.  239 
One of the first pieces of evidence demonstrating post-transcriptional regulation of Il10 mRNA 240 
expression came from studies of the 3’ untranslated regions (UTR) of the Il10 mRNA, which showed the 241 
existence of adenylate-uridylate (AU) rich elements (AREs), capable of mediating mRNA decay [39]. 242 
These ARE sequences recruit several ARE-binding proteins that positively or negatively regulate mRNA 243 
stability [28]. One such protein is TTP that was found to promote rapid mRNA decay of several 244 
transcripts, including that of TNF [40], by initiating the assembly of RNA decay machinery [41, 42]. 245 
More recently, several cytokines, such as IL-10, were found to be targets of TTP [24, 25]. In line with 246 
this, the t1/2 of Il10 mRNA induced upon 5 h of LPS stimulation of Mɸ was increased in the absence of 247 
TTP [25]. As we now show, TTP also influences the t1/2 of the Il10 mRNA induced by TLR2 activation, 248 
but in this case it targets the Il10 mRNA earlier than observed for LPS. This difference between TLR2 249 
and TLR4 is most likely related to differential TTP activation/inactivation, as the transcriptional pattern 250 
of TTP in BMMɸ activated through TLR2 or TLR4 is similar. Furthermore, TRIF deficiency led to less 251 
TTP transcription in LPS-stimulated BMMɸ than in WT cells. Altogether, our data suggest that a direct 252 
relation between TTP transcription and function is not in place, in support of the importance of TTP 253 
regulation by post-translational modifications, Specifically, the activity of TTP is negatively regulated by 254 
the MAPK p38 [24, 25, 29, 30]. Importantly, the impact of p38 control of TTP-mediated mRNA 255 
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destabilization varies with target mRNAs. For example, whereas in the case of TNF a certain p38 256 
independence was observed [43], for IL-1α [43], CXCL1 [44] and IL-10 [24] the inhibition of p38 257 
activation was important for the TTP-mediated decay. We observed a TRIF-mediated increase of p38 258 
signaling, which is in line with previous studies [2, 45], and associated it with an increased t1/2 of Il10 259 
mRNA. It is thus likely that the activation of TRIF and p38 upon TLR4 triggering are stabilizing the Il10 260 
mRNA in part through TTP inactivation. Of note, our data may look in apparent disagreement with 261 
previous studies showing that IL-10 negatively regulate p38 [43, 46]. However, we observed stronger p38 262 
activation during an initial phase of TLR4 stimulation (up to 120 minutes). During this initial period, the 263 
amount of IL-10 protein secreted by TLR2- or TLR4-stimulated BMMɸ is similar (data not shown), so, at 264 
this stage, differences in p38 are likely not related to differential regulation by IL-10. Finally, we report 265 
that the MAPK ERK does not regulate IL-10 expression post-transcriptionally, although inhibition of this 266 
cascade reduced the amount of IL-10 secreted by TLR4-stimulated BMMɸ. This observation is in line 267 
with previous reports demonstrating that ERK is involved in the molecular mechanisms regulating Il10 268 
gene expression [6]. Thus, it is possible that ERK plays a major role in transcriptionally regulating IL-10, 269 
with p38 additionally participating at the post-transcriptional level. This observation suggests that the 270 
signaling cascades downstream of ERK and p38 diverge for example in what concerns TTP regulation. 271 
TRIF signals appear therefore to enhance the activation of the MAPK p38, so that TTP-mediated 272 
mRNA degradation is delayed. One possible mediator of this mechanism is the MAPK phosphatase 273 
DUSP1. DUSP-1 was shown to impair p38 activity [47-49], to impair TTP expression and production by 274 
inhibiting p38 activation [50] and to induce the reduction of Il10 mRNA stability [49]. Also, DUSP1-/- 275 
mice challenged in vivo with LPS showed increased production of IL-10 [51]. Since in response to LPS 276 
stimulation, TRIF-/- macrophages showed decreased levels of DUSP1 activation relatively to WT cells 277 
[22], it is possible that the differences observed in terms of p38 activation are not directly related to 278 
DUSP1. Further studies are however needed to unequivocally answer this question.   279 
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The mechanism proposed in this study is likely to affect pro-inflammatory cytokines in addition to 280 
IL-10. Activation of the TRIF pathway with subsequent enhanced p38 activation and an increase in the 281 
t1/2 of cytokine mRNAs, promotes a specific post-transcriptional control that may shift the immune 282 
response towards a more inflammatory type. In this scenario, ensuring that IL-10 is also enhanced might 283 
be of importance for the achievement of a balanced response. IL-10 has been implicated in inducing its 284 
own transcription via STAT3 activation in human monocyte-derived Mɸ [52], which would constitute an 285 
autocrine loop for IL-10 induction. IL-10 induces the destabilization of its own mRNA possibly via a 286 
secondary factor [53]. More recently, it has been shown that in addition to being a target of TTP, IL-10 is 287 
itself an activator of TTP, by reducing late p38 activity [43, 54]. Thus, in situations when IL-10 is being 288 
produced, TTP is activated. This mechanism ensures a shut-down of pro-inflammatory cytokines, such as 289 
TNF and IL-1α [55], IL-6 and IL23p19 [55] or chemokines [56], mediated by IL-10 induced mRNA 290 
decay. It is also possible that this mechanism subsequently limits IL-10 translation, thus guaranteeing the 291 
appropriate balance of the immune response. For both TLR2 and TLR4 stimulation of BMMɸ, early IL-292 
10 protein was detected in similar amounts or was higher for TLR4 signals, thus suggesting that in our 293 
system, the differences in the stability of the Il10 mRNA observed are likely not due to distinct IL-10 294 
autocrine signaling. 295 
The broad array of regulatory mechanisms in place to modulate IL-10 expression might be a 296 
consequence of IL-10 induction by a variety of stimuli in many different cell types. Uncovering the 297 
extensive network underlying these mechanisms will be of interest to targeted modulation of IL-10 298 
production. As we show here, this extensive network of molecular mechanisms differs with the type of 299 
stimuli and involves many layers of regulation, including at the post-transcriptional level. We show that 300 
although the early induction of Il10 transcription in BMMɸ by TLR2 and TLR4 is similar, the cell then 301 
fine tunes the amount of IL-10 via a mechanism of post-transcriptional regulation mediated by 302 
TRIF/p38/TTP, which discriminates between these two TLRs. This mechanism operates in BMMɸ 303 
sensing whole bacteria and allows for distinct IL-10 induction by TLR2- versus TLR4-activating 304 
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microbes. As a consequence, TLR4 stimulation of BMMɸ leads to higher levels of IL-10 production than 305 
TLR2 activation, which may be beneficial to inhibit inflammatory pathologies or on the other hand 306 
manipulated to the advantage of the pathogen. 307 
308 
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Materials and Methods 309 
Animals 310 
Females of eight to twelve weeks of age on the C57BL/6 background were used. Wild type (WT) mice 311 
were ordered from Charles River (Barcelona, Spain). TLR2
-
/
-
 [57] and TLR4
-
/
-
 [58] animals were bred 312 
and maintained at ICVS. TRIF
-
/
-
 [5] mice were from MRC-NIMR. All mouse protocols followed the 313 
European Union Directive 86/609/EEC and were previously approved by the national authority Direcção 314 
Geral de Veterinária. 315 
Cell culture 316 
Complete (c) DMEM was prepared by supplementing DMEM (GIBCO) with 10% FBS, 1% sodium 317 
pyruvate, 1% HEPES and 1% L-glutamine (all from GIBCO). BMMɸ were generated in cDMEM 318 
supplemented with 20% of L929-cell conditioned media (LCCM). On day 0, 4x10
6
 cells in 8 mL were 319 
plated per petri dish (Sterilin) and kept at 37ºC and 5% CO2. Cell cultures were fed on day 4 with 10 mL 320 
of cDMEM-20% LCCM. BMMɸ were recovered on day 7 of culture, counted and stimulated for different 321 
time-points as appropriate. TTP
-
/
-
 and control (WT) cells were from littermate male mice of 6-16 weeks 322 
of age that had been backcrossed 28 generations into C57Bl/6NTac mice and have been described 323 
previously [59]; cells were used to derive, as above, BMMɸ, except that 30% of LCCM was used. 324 
Bacteria 325 
Mycobacterium tuberculosis H37Rv strain Pasteur, a kind gift from P. J. Cardona (Barcelona), was grown 326 
in Proskauer Beck (PB) medium containing 0.05% Tween 80 to mid-log phase and frozen in PB medium 327 
and 30% glycerol at –80°C. The DH5X strain of E. coli (ICVS) and S. enteriditis (a gift from J. Azeredo, 328 
INL) were grown in Lysogeny broth (LB), to mid-log phase and frozen in PBS 1X and 30% glycerol at -329 
80ºC. L. moncytogenes (ICVS) was grown in Antibiotic Medium 3. E. coli was heat inactivated for 60 330 
min at 95ºC, S. enteriditis was heat inactivated for 30 min at 72ºC and L. monocytogenes for 60 min at 331 
62ºC prior to cell stimulation. All bacteria were added to the cell cultures at a multiplicity of infection of 332 
two. 333 
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Reagents 334 
LPS (S. Minnesota, Sigma) and Pam3CSK4 (InvivoGen) were used at 25 ng/mL and 2 μg/mL, 335 
respectively. Actinomycin D (ActD) (Sigma) was used at 10 μg/mL and added to the cell cultures 1 h 336 
post-stimulation, when indicated. p38 (SB 203580) and ERK (PD0325901) inhibitors, kind gifts of Prof. 337 
Sir P. Cohen, were used at 2.5 μM and 0.1 μM [60], respectively, and added to the cell cultures 50 min 338 
post-stimulation. Cell culture grade DMSO (Sigma) was used as a vehicle control, when appropriate. 339 
ELISA 340 
IL-10 quantification in the cell culture supernatants was performed by ELISA following the 341 
manufacturer’s instructions (eBioscience). 342 
RNA extraction, cDNA and quantitative real time PCR 343 
Total RNA from stimulated and non-stimulated cell culture samples was extracted at different time-points 344 
with TRIzol® 143 Reagent (Invitrogen, San Diego, CA) and converted to cDNA according to the 345 
manufacturer’s instructions (Fermentas). Il10 and TTP gene expression were assessed by real-time PCR 346 
using SYBR Green (Fermentas) and TaqMan MasterMix (Applied Byosistems) and normalized against 347 
ubiquitin or Hypoxanthine Phosphoribosyltransferase 1 (Hprt1) expression, respectively, as previously 348 
described [12]. 349 
Western Blot (WB) 350 
BMMɸ were rested for 5 h in 1% FBS – cDMEM prior to stimulation. At the indicated time points post 351 
stimulation, cell culture supernatants were discarded and cells gently washed with apyrogenic 1X PBS 352 
(GIBCO). Protein extracts were obtained with a lysis buffer solution (100 mM Tris-HCl pH8; 10% 353 
glycerol; 1 mM EDTA pH8; 5 mM MgCl2; 50 mM NaCl; 1% NP-40; 1x protease inhibitor cocktail 354 
(Roche); 1x phosphatase inhibitor cocktails II and III (Sigma); dH2O) for 20 minutes on ice. Extracts 355 
were kept at -80ºC until further use. Samples were then centrifuged at 13000 rpm for 15 min and protein 356 
extracts recovered. Immediately before use, protein extracts were heated 5 min at 95ºC and 20 μg of each 357 
sample resolved in a 12% SDS-PAGE and then transferred to nitrocellulose membranes. Total and 358 
18 
phospho p38 (Threonine 180 and Tyrosine 182) and total and phospho ERK (Threonine 202/185 and 359 
Tyrosine 204/187) were detected by using specific antibodies (all from Cell Signaling). The secondary 360 
antibody was anti-rabbit-HRP (Cell Signaling). The membranes were developed with SuperSignal Femto 361 
substrate (Thermo Scientific) and read by a Universal Hood II (Bio-Rad). Quantity one (Bio-Rad) 362 
software was used to analyze the results. 363 
Statistical analysis 364 
Data are expressed as Mean ± SEM and analyzed by the two-way ANOVA test with a Bonferroni post-365 
test or by the two-tailed Student´s t test, as indicated. The p values considered as having statistical 366 
significance were *, p ≤0.1; **, p ≤0.01 and *** p≤0.001. 367 
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Figure legends 561 
Figure 1. Distinct post-transcriptional regulation of IL-10 through TLR2 versus TLR4 signaling in 562 
BMMɸ. WT BMMɸ were stimulated with Pam3CSK4 (2 µg/mL) or LPS (25 ng/mL) (A, B and C) or 563 
with CpG (1 µM) (D, E and F). (A) At the indicated time points post-stimulation with Pam3CSK4 564 
(crosses) or LPS (open squares) total RNA was harvested, converted to cDNA and the Il10 mRNA 565 
expression determined by real-time PCR and normalized to ubiquitin. (B) At 1 h post-stimulation with 566 
Pam3CSK4 (crosses) or LPS (open squares), ActD was added to the cultures and 30, 60 or 90 min later 567 
the Il10 mRNA expression determined as in (A). The percentage of Il10 mRNA present at each time point 568 
is relative to the amount of Il10 mRNA measured at 1 h post-stimulation in the absence of ActD. The Il10 569 
mRNA half-life (t1/2) was calculated as the time post ActD addition where 50% of Il10 mRNA was still 570 
present. (C) 6 h post-stimulation of BMMɸ with Pam3CSK4 or LPS, cell culture supernatants were 571 
collected and the amount of IL-10 measured by ELISA. (D, E and F) BMMɸ were stimulated with CpG 572 
(diamonds) and treated as in (A), (B) and (C), respectively. Results are Mean ± SEM of 3 (A, B and C) or 573 
2 (D, E and F) independent experiments. Each time point represented was performed in triplicate for each 574 
experiment. p values were determined by the two-way ANOVA with a Bonferroni post-test (A and B) or 575 
by the Student´s t test (C); ***p<0.001.  576 
Figure 2. TRIF signaling enhances the stability of Il10 mRNA. (A) BMMɸ generated from WT (solid 577 
line) or TRIF
-
/
-
 (dashed line) mice were stimulated with LPS (25 ng/mL) and the Il10 mRNA half-life 578 
(t1/2) was determined at 1h post-stimulation, as described in Figure 1B. (B) 6 h post-stimulation of WT 579 
(black bar) or TRIF-/- (white bar) BMMɸ with LPS the cell culture supernatants were collected and the 580 
amount of IL-10 measured by ELISA. Results are Mean ± SEM of 2 independent experiments. Each time 581 
point represented was performed in triplicate for each experiment. p values were determined by the two-582 
way ANOVA with a Bonferroni post-test (A) or by the Student´s t test (B); ***p<0.001. 583 
25 
Figure 3. p38 mediates the TRIF-induced stability of the Il10 mRNA. (A and B) WT BMMɸ were 584 
stimulated with Pam3CSK4 (2 µg/mL; crosses) or LPS (25 ng/mL; open squares) and, at the indicated 585 
time points post-stimulation, total cell extracts were prepared, separated in SDS-PAGE and the ratio of 586 
phospho p38/total p38 (A) or phospho ERK/total ERK (B) assessed by WB. (C and D) WT (solid line) or 587 
TRIF
-
/
-
 (dashed line) BMMɸ were stimulated with LPS (25 ng/mL) and the ratio of phospho p38/total 588 
p38 (C) or phospho ERK/total ERK (D) assessed by WB as indicated in (A) and (B). Data represent 589 
pooled protein extracts from each three replicates per condition. Shown is a representative Western Blot 590 
from the 3 independent experiments performed and the resulting quantification. Results are Mean ± SEM 591 
of 3 independent experiments. Each time point represented was performed in triplicate for each 592 
experiment. (E and F) WT BMMɸ were stimulated with LPS for 50 min. At this time point, DMSO (as a 593 
control, open squares), SB203580 (p38 inhibitor, at 2.5 µM; close squares) or PD0325901 (ERK 594 
inhibitor, at 0.1 µM; close circles) were added to the cultures. Ten min later, ActD was added to all wells 595 
and the t1/2 of the Il10 mRNA determined as in Figure 1B. (G and H) Cells were treated as before, but 596 
with no addition of ActD, and at 6 h post-stimulation the supernatants were collected and the amount of 597 
IL-10 measured by ELISA. Results are Mean ± SEM of 2 independent experiments. Each time point 598 
represented was performed in triplicate for each experiment. p values were determined by the two-way 599 
ANOVA with a Bonferroni post-test (A-F) or by the Student´s t test (G and H); * p<0.05; ** p<0.01; 600 
***p<0.001. 601 
Figure 4. Absence of TTP delays the early degradation of the Il10 mRNA induced upon TLR2-signaling. 602 
(A and B) WT (solid lines) or TTP
-
/
-
 (dashed lines) BMMɸ (generated from frozen cells) were stimulated 603 
with LPS (25 ng/mL, open squares) or Pam3CSK4 (2 µg/mL, crosses) for 1h and the Il10 mRNA t1/2 was 604 
determined upon addition of ActD as described in Figure 1B. (C and D) WT (black bars) or TTP
-
/
-
 (white 605 
bars) BMMɸ were generated and stimulated as above, except that ActD was not added, and the amount of 606 
IL-10 in the cell culture supernatants was measured by ELISA 6 h post-stimulation. (E) WT BMMɸ were 607 
stimulated with LPS (25 ng/mL, open squares) or Pam3CSK4 (2 µg/mL, crosses) and the TTP mRNA 608 
26 
measured over time as indicated in Figure 1A. (F) WT (solid lines) or TRIF
-
/
-
 (dashed lines) BMMɸ were 609 
stimulated with LPS and the TTP mRNA measured over time as indicated in Figure 1A. Results are Mean 610 
± SEM of 2 (A-D) or 3 (E and F) independent experiments. Each time point represented was performed in 611 
triplicate for each experiment. p values were determined by the two-way ANOVA with a Bonferroni post-612 
test (A, B, E and F) or by the Student´s t test (C and D); * p<0.05; ** p<0.01; ***p<0.001. 613 
Figure 5. Differential post-transcriptional regulation of IL-10 by TLR2 versus TLR4 upon BMMɸ 614 
stimulation with intact bacteria. (A and B) WT BMMɸ were stimulated with heat-killed E. coli (crosses), 615 
S. enteriditis (diamonds), L. monocytogenes (inverted triangles) or with live M. tuberculosis H37Rv (open 616 
circles) at a moi of 2. The Il10 mRNA t1/2 was determined at 1h post-stimulation, as indicated in Figure 617 
1B. (C) WT (solid lines) or TRIF
-
/
-
 (dashed lines) BMMɸ were stimulated with heat-killed E. coli (moi of 618 
2) and the Il10 mRNA t1/2 determined at 1h post-stimulation, as indicated in Figure 1B. (D) WT BMMɸ 619 
were stimulated with heat-killed E. coli (moi of 2) in the presence of DMSO (as a control, solid lines) or 620 
of SB203580 (p38 inhibitor, at 2.5 µM; dashed lines) and the Il10 mRNA t1/2 determined at 1h post-621 
stimulation, as indicated in Figure 1B. (E) 6 h post-stimulation of WT (black bar) or TRIF
-
/
-
 (white bar) 622 
BMMɸ with E. coli the cell culture supernatants were collected and the amount of IL-10 measured by 623 
ELISA. (F) WT BMMɸ were stimulated with E. coli in the presence of DMSO (as a control, black bar) or 624 
of SB203580 (p38 inhibitor, white bar) for 6 h and the IL-10 protein present in the supernatants of the 625 
stimulated cultures determined by ELISA. Results are Mean ± SEM of 3 (A and B) or 2 (C-F) 626 
independent experiments. Each time point represented was performed in triplicate for each experiment. p 627 
values were determined by the two-way ANOVA with a Bonferroni post-test (A-D) or by the Student´s t 628 
test (E and F); * p<0.05; ** p<0.01; ***p<0.001. 629 
630 
27 
Supplemental Figure legends 631 
Figure S1. IL-10 production by BMMɸ in response to increasing doses of Pam3CSK4 (A) or LPS (B). 632 
WT BMMɸ were stimulated with the indicated doses of Pam3CSK (A) or LPS (B) and 6 h post-633 
stimulation the amount of IL-10 in the culture supernatants measured by ELISA. Represented is the Mean 634 
± SEM of 2 independent experiments. Each time point represented was performed in triplicate for each 635 
experiment. 636 
Figure S2. (A) WT BMMɸ were stimulated with LPS (25 ng/mL) and 1h (open suares) or 3h (inverted 637 
triangles) later the Il10 mRNA t1/2 determined as indicated in Figure 1B. (B) WT (solid lines) or TRIF
-
/
-
 638 
(dashed lines) BMMɸ were stimulated with LPS (25 ng/mL) and at the indicated time points the Il10 639 
mRNA determined as in Figure 1A. Represented is the Mean ± SEM of 2 independent experiments. Each 640 
time point represented was performed in triplicate for each experiment. p values were determined by the 641 
two-way ANOVA with a Bonferroni post-test; ***p<0.001. 642 
Figure S3. (A, B and C) WT BMMɸ were stimulated with live M. tuberculosis H37Rv (open circles) or 643 
with heat-killed E. coli (crosses) at a moi of 2. At the indicated time points post-stimulation the 644 
expression of Il10 (A) or TTP (B) mRNA was determined as detailed in Figure 1A. The ratio of phospho 645 
p38/total p38 (C) was also determined as detailed in Figure 3A. (D-F) WT (solid lines) or TRIF
-
/
-
 (dashed 646 
lines) BMMɸ were stimulated with heat-killed E. coli (moi of 2) and the expression of Il10, TTP or the 647 
ratio phospho p38/total p38 were determined as before. Represented is the Mean ± SEM of 2 independent 648 
experiments. Each time point represented was performed in triplicate for each experiment. p values were 649 
determined by the two-way ANOVA with a Bonferroni post-test; * p<0.05; ** p<0.01; ***p<0.001. 650 
651 
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